OIRA Conclusion of EO 12866 Regulatory Review
| RIN: 0910-AI72 View EO 12866 Meetings | Received Date: 01/05/2023 |
| Title: Use of Salt Substitutes to Reduce the Sodium Content in Standardized Foods | |
| Agency/Subagency: HHS / FDA | Stage: Proposed Rule |
| Concluded Action: Consistent with Change | Concluded Date: 03/24/2023 |
| Legal Deadline: None | Economically Significant: Yes |
| Publication Date: 04/10/2023 | Unfunded Mandates: No |
| Major: Yes | Related To Homeland Security: No |
| Regulatory Flexibility Analysis Required: No | Small Entities Affected: |
| Federalism Implications: No | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
| International Impacts: No | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
| Pandemic Response: No | |
An official website of the United States government



